


Searching News Database: adhesion
HSMN NewsFeed - 17 Mar 2022
New Cardinal Health Surgical Drape Helps Reduce Surgical Site Contamination Risk
New Cardinal Health Surgical Drape Helps Reduce Surgical Site Contamination Risk
HSMN NewsFeed - 3 Sep 2020
Innovent Announces NMPA Granted Marketing Approval for SULINNO(R) (Adalimumab Injection) in China
Innovent Announces NMPA Granted Marketing Approval for SULINNO(R) (Adalimumab Injection) in China
HSMN NewsFeed - 7 Jul 2020
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
HSMN NewsFeed - 28 Nov 2018
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
HSMN NewsFeed - 23 Aug 2017
Channel Medsystems(R) Secures $14.1mm Financing for Office-Based Treatment of Heavy Menstrual Bleeding
Channel Medsystems(R) Secures $14.1mm Financing for Office-Based Treatment of Heavy Menstrual Bleeding
HSMN NewsFeed - 26 Jun 2017
Channel Medsystems(R) Earns CE Mark Approval for the Cerene(R) Cryotherapy Device
Channel Medsystems(R) Earns CE Mark Approval for the Cerene(R) Cryotherapy Device
HSMN NewsFeed - 19 Oct 2016
CollPlant Receives CE Mark for Vergenix(TM)STR for Treatment of Tendinopathy
CollPlant Receives CE Mark for Vergenix(TM)STR for Treatment of Tendinopathy
HSMN NewsFeed - 29 Apr 2016
Stryker’s Spine Division Debuts 3D-Printed Tritanium(R) Posterior Lumbar Cage at AANS Meeting
Stryker’s Spine Division Debuts 3D-Printed Tritanium(R) Posterior Lumbar Cage at AANS Meeting
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 1 Dec 2015
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
HSMN NewsFeed - 13 Aug 2015
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
HSMN NewsFeed - 19 May 2014
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
HSMN NewsFeed - 29 Apr 2014
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
HSMN NewsFeed - 23 Apr 2014
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
HSMN NewsFeed - 13 Mar 2014
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
HSMN NewsFeed - 4 Mar 2014
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
HSMN NewsFeed - 30 Oct 2013
Aurora Spine Announces First US Surgery and Global Launch of AmnioPUR(TM)
Aurora Spine Announces First US Surgery and Global Launch of AmnioPUR(TM)
HSMN NewsFeed - 23 Oct 2013
Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union
Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union
HSMN NewsFeed - 13 Mar 2013
Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting
Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting
HSMN NewsFeed - 28 Feb 2013
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
HSMN NewsFeed - 29 Jan 2013
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
HSMN NewsFeed - 4 Jan 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
HSMN NewsFeed - 16 Mar 2012
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
HSMN NewsFeed - 31 Aug 2011
DSM ComfortCoat(R) Hydrophilic Coating Enhances the Capabilities Of PendraCare PRIMUM Guiding Catheters
DSM ComfortCoat(R) Hydrophilic Coating Enhances the Capabilities Of PendraCare PRIMUM Guiding Catheters
HSMN NewsFeed - 16 Mar 2011
MAQUET Cardiovascular Receives European CE Mark for FUSION BIOLINE Vascular Graft
MAQUET Cardiovascular Receives European CE Mark for FUSION BIOLINE Vascular Graft
HSMN NewsFeed - 27 Jan 2011
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab(R)
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab(R)
HSMN NewsFeed - 20 Jan 2011
Anika Therapeutics Appoints Industry Veteran Jeffery S. Thompson to Board of Directors
Anika Therapeutics Appoints Industry Veteran Jeffery S. Thompson to Board of Directors
HSMN NewsFeed - 10 Jun 2010
Medline Expands Surgical Suite Product Portfolio With Agreement to Distribute Proxy Biomedical Surgical Mesh
Medline Expands Surgical Suite Product Portfolio With Agreement to Distribute Proxy Biomedical Surgical Mesh
HSMN NewsFeed - 22 Apr 2009
MiMedx Group Announces FDA Clearance to Market the Parads Vaso Shield Device
MiMedx Group Announces FDA Clearance to Market the Parads Vaso Shield Device
HSMN NewsFeed - 23 Mar 2009
Medline Introduces MatriStem(TM) Extracellular Matrix That Taps Body's Own Capabilities to Repair Tissue
Medline Introduces MatriStem(TM) Extracellular Matrix That Taps Body's Own Capabilities to Repair Tissue
HSMN NewsFeed - 9 Mar 2009
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
HSMN NewsFeed - 23 Feb 2009
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
HSMN NewsFeed - 19 Feb 2009
Small Bone Innovations Receives European Union CE Mark for Its PRECISE SD Distal Volar Radius Plating System
Small Bone Innovations Receives European Union CE Mark for Its PRECISE SD Distal Volar Radius Plating System
HSMN NewsFeed - 21 Jan 2009
Novel Product for Post Surgical Scar Formation Entering Clinical Development
Novel Product for Post Surgical Scar Formation Entering Clinical Development
HSMN NewsFeed - 2 Oct 2008
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
HSMN NewsFeed - 5 Sep 2008
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
HSMN NewsFeed - 25 Aug 2008
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
HSMN NewsFeed - 18 Jul 2008
SyntheMed Appoints Corinne Mundin as Director, International Market Development
SyntheMed Appoints Corinne Mundin as Director, International Market Development
HSMN NewsFeed - 17 Jun 2008
NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant
NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant
HSMN NewsFeed - 29 May 2008
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
HSMN NewsFeed - 14 May 2008
Advanced Medical Optics Receives FDA Clearance For iFS(TM) Advanced Femtosecond Laser
Advanced Medical Optics Receives FDA Clearance For iFS(TM) Advanced Femtosecond Laser
HSMN NewsFeed - 8 May 2008
Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
HSMN NewsFeed - 22 Apr 2008
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
HSMN NewsFeed - 31 Mar 2008
SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent
SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent
HSMN NewsFeed - 5 Feb 2008
Ceremed's OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
Ceremed's OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
HSMN NewsFeed - 21 Jan 2008
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
HSMN NewsFeed - 25 Sep 2007
Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
HSMN NewsFeed - 24 Sep 2007
ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
HSMN NewsFeed - 20 Sep 2007
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
HSMN NewsFeed - 2 Jul 2007
Tenaxis Medical Inc. Announces First Human Use of ArterX(TM) Vascular Sealant
Tenaxis Medical Inc. Announces First Human Use of ArterX(TM) Vascular Sealant
HSMN NewsFeed - 17 Apr 2007
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
HSMN NewsFeed - 9 Apr 2007
Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers
Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers
HSMN NewsFeed - 28 Mar 2007
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
HSMN NewsFeed - 12 Mar 2007
Atrium Medical Receives CE Mark for its ClearWay(TM) RX Therapeutic Perfusion Catheter
Atrium Medical Receives CE Mark for its ClearWay(TM) RX Therapeutic Perfusion Catheter
HSMN NewsFeed - 11 Jan 2007
Synovis Life Technologies Granted Important FDA Indication and U.S. Patent for Veritas(R) Collagen Matrix
Synovis Life Technologies Granted Important FDA Indication and U.S. Patent for Veritas(R) Collagen Matrix
HSMN NewsFeed - 5 Dec 2006
Micromet, Inc. and Serono Amend Collaboration Agreement and Continue Development of Adecatumumab (MT201)
Micromet, Inc. and Serono Amend Collaboration Agreement and Continue Development of Adecatumumab (MT201)
HSMN NewsFeed - 16 Nov 2006
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
HSMN NewsFeed - 1 Nov 2006
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
MediciNova Announces the Acquisition of Two Novel Antithrombotic Agents from Meiji Seika Kaisha, Ltd.
HSMN NewsFeed - 18 Oct 2006
AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
HSMN NewsFeed - 13 Oct 2006
Independent Studies on FzioMed's Anti-Adhesion Gel Presented at Spine Meetings
Independent Studies on FzioMed's Anti-Adhesion Gel Presented at Spine Meetings
HSMN NewsFeed - 29 Sep 2006
OMRIX Biopharmaceuticals Announces New Strategic Product Development Programs
OMRIX Biopharmaceuticals Announces New Strategic Product Development Programs
HSMN NewsFeed - 6 Sep 2006
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
Additional items found! 152
Members Archive contains
152 additional stories matching:
adhesion
(Password required)
adhesion
(Password required)
